共 72 条
- [1] Norén GN(2006)Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events Stat Med 25 3740-3757
- [2] Bate A(2003)Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting Pharmacoepidemiol Drug Saf 12 517-521
- [3] Orre R(2004)Using disproportionality analysis as a tool to explore drug-drug interavtions in AERS database Pharmacoepidemiol Drug Saf 13 S247-877
- [4] Edwards IR(2018)Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media Brief Bioinform 19 863-3070
- [5] Almenoff JS(2019)Review of statistical methodologies for detecting drug-drug interactions using spontaneous reporting systems Front Pharmacol 10 1319-495
- [6] DuMouchel W(2008)A statistical methodology for drug-drug interaction surveillance Stat Med 27 3057-49
- [7] Kindman LA(2007)Detecting signals of drug-drug interactions in a spontaneous reports database Br J Clin Pharmacol 64 489-786
- [8] Yang X(2014)Safety risk evaluation methodology in detecting the medicine concomitant use risk which might cause critical drug rash Jpn J Pharmacoepidemiol 19 39-10
- [9] Ram D(2017)Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems Eur J Clin Pharmacol 73 779-574
- [10] Yang X(2002)A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Pharmacoepidemiol Drug Saf 11 3-394